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Aim
•  Implement a protocolized vaccination program for patients on 
immuno­suppressive­medications­to­increase­influenza­and­pneu-
mococcal vaccination adherence by at least 15% for each vaccine
Measures
•  Retrospective chart analysis of 756 patients on biologic agents in a 
primary care setting
•  Patients were evaluated for compliance with CDC guidelines for 
immunocompromised individuals for the 3 vaccines listed below:
 1 Influenza
  2  Prevnar 13
  3 Pneumovax 23 
Intervention
•  Educational outreach sessions 
were performed for all providers 
of internal medicine and 
rheumatology practices 
biannually
•  Information sheets were 
displayed in all involved 
practices
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Problem
•  Immunosuppressive agents 
have changed the course of 
debilitating autoimmune 
conditions, but come with  
an increased risk of vaccine 
preventable infections1
•  Vaccine indications and  
dosing recommendations  
are not being adhered to 
regularly by primary and 
speciality practices
Background
•  Multiple organizations 
recommend scheduled 
influenza­and­pneumococcal­
vaccinations in all patients on 
chronic immunosuppression2,3
•  According to the Center for 
Disease Control (CDC) in 2014, 
vaccination adherence remains 
low amongst high-risk persons 
aged 19–64 years4
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Current Results
•  There was an increase in overall vaccination adherence by 11% 
(n=81) in an at risk patient population








Influenza Prevnar 13 Pneumovax 23
■ Pre Intervention   ■ Post Intervention











■ Pre Intervention   ■ Post Intervention
Future Steps
•  A vaccination clinic is being developed in order to improve 
access to patients requiring vaccinations
•  We will optimize our best practice alert advisory through 
electronic medical record to notify providers of vaccine 
schedules for our at risk population
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